ClinicaliQ Trial Snapshot
- Barts Endocarditis Research Registry — Recruiting • Cardiology / Cardiovascular • NCT06434012.
- What is being tested: The registry evaluates infective endocarditis (IE) characteristics, current imaging practices, and implementation of European Society of Cardiology (ESC) guidelines in a defined patient population.
- Patient eligibility: The registry includes patients diagnosed with infective endocarditis presenting to Barts Healthcare services, capturing a representative cohort of IE cases across the institution.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The Barts Endocarditis Research Registry is being set up to give a unique opportunity to assess the characteristics of Infective Endocarditis (IE) in our population cohort, the current use of imaging techniques, as well as the implementation of the ESC guidelines and its consequence in terms of prognosis. All this will help improve the diagnosis and management of IE. The registry will also form the core of all our subsequent work, including interventional studies. The endocarditis research registry is to record the epidemiological, demographic, microbiological, surgical and outcome data in…
Eligibility Snapshot
- : * • Patients aged 16 and over (Patients under 16 years of age are not admitted to Barts Heart Centre) * Patients admitted to Barts Heart Centre with confirmed Endocarditis (see above) * Patients attending outpatients with confirmed/suspected Endocarditis * Patients with possible IE who complete treatment for endocarditis * Patients with cardiac device related Endocarditis * Patients with the ability to provide informed consent
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.